Collaborations and Partnerships CBNS researchers have a long history of collaboration with other universities, research centres, industry and medical organisations. These collaborations take a wide variety of forms – from formal relationships such as Linkage Projects or contract research, to informal and ad hoc collaborations.
Intellectual Property and Commercialisation Policy The CBNS IP and Commercialisation Committee (IPCC) provides advice for Intellectual Property (IP) management to CBNS CIs. The IPCC comprises the Centre Executive (Director, Deputy Director and Manager), plus the Business Development Manager from the Administering Organisation (Monash). In discussing IP from collaborating organisations, the IPCC co-opts the Business Development Manager (or equivalent) from that organisation.
Intellectual Property CBNS does not own project intellectual property (IP) resulting from CBNS activities. Project IP is owned by the (administering, collaborating or partner) organisation making the major inventive contribution to the IP. Whilst a single organisation assumes control of project IP, in the cases of cross institutional participation in project IP generation, beneficial interest in project IP, is determined by relative contributions to IP generation based on cash and in-kind contributions to that project (cash is weighted by a factor of 2).
36 CBNS Annual Report 2019
CBNS maintains an Intellectual Property Register, which includes up to date details of CBNS IP and each organisation’s background IP. It consists of: • the owners of each item of background and IP and the proportion of ownership • any and all third party interests in background and IP • any patents or patent applications relating to
Commercialisation The organisation owning the project IP supports protection and commercialisation through its IP commercialisation group and meets the cost of protection.
CBNS commercial partners provide real world advice to CIs but also provide a potential path-to-market and a defined route to impact. As such, industry partners have the right of first refusal to a license to exploit project IP on terms to be agreed. In relation to the commercialisation of project IP, all parties negotiate in good faith to agree on a Commercialisation Lead and the terms of any Commercialisation. The Commercialisation Lead has the right to sublicense project IP in the interests of all parties and CBNS, without restricting the use of the project IP for research, teaching and scholastic endeavours.
